We have launched a phase-II trial to assess SSTR2 expression by 68Ga-DOTATATE PET/CT in symptomatic relapsing and refractory multiple myeloma patients (SCARLET trial—NCT04379817). The gene discussed is SSTR2; the disease is AL amyloidosis.